Medical tests are performed to detect or diagnose a health issue, determine an appropriate treatment plan, confirm that a therapeutic intervention is working as intended, or monitor the progression of a condition. Medical tests can vary from evaluating bodily specimens, such as blood or urine, to invasive examinations, including biopsies or endoscopies. While most medical testing requires a healthcare professional, some test, such as monitoring blood glucose levels, can be administered by the individual patient in an outpatient setting.
Family history can be viewed as the first stop in the assessment of genetic risks for any individual. For many genetic disorders there will be no obvious signs of symptoms until significant m...
In this presentation, Arvid Carlsson, who was awarded the Nobel prize in 2000 for his discovery of the transmitter role of dopamine, will be interviewed by Elias Eriksson. The following aspec...
9:00AM Pacific time, 11:00AM Central time, 12:00PM Eastern timeClinical Controversies Recently, both national and international authorities have promulgated conflicting statements on vita...
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...
Working with animals carries legal, scientific and ethical responsibilities. These responsibilities merge as we strive to humanely use the least number of animals necessary to provide t...
Optimising experimental design needs a sound understanding of basic principles and a good appreciation of a range of designs and when to use them. More than ten years ago it was clear t...
A number of elements come into the mix when trying to optimise experimental design. Among these are having clear objectives, setting up valid comparisons, knowing how to avoid bias during the...
DATE: February 3rd, 2016
TIME: 10am pacific time, 1pm eastern time
Instituting a laboratory outreach program achieves a multitude of benefits beyond driving optimization, test...
Date: December 9, 2015 10AM Pacific, 1PM Eastern
July 7, 2015, the U.S. Food and Drug Administration reviewed and approved ENTRESTO™ (sacubitril/valsartan) tablets to reduce the risk...
Live Webinar: December 2, 2015 8:00am PST
In recent years, there has been a dramatic increase in the number of new designer drugs designed to mimic the effects of controlled substances. &n...
Presence of anti-PS/PT IgG or IgM antibodies indicates a high risk category of patients
Antiphospholipid antibodies are not directed against phospholipids, but rather to phospholipid-prote...
Presence of anti-PS/PT IgG or IgM antibodies indicates a high risk category of patients
Antiphospholipid antibodies are not directed against phospholipids, but rather to phospholipid-prote...
DATE: November 19, 2015
TIME: 7:00AM Pacific, 9:00AM Central, 10:00AM Eastern, 3:00PM GMT
Diabetes represents a serious global epidemic. Diabetes causes its own direct adverse ...
The assessment of serum lipid and lipoprotein levels is a common procedure which affects the management of the risk of atherothrombotic cardiovascular disease (CVD) in large numbers of patien...
While genomics has been used as a tool for research for many years, globally there is increasing momentum to deploy microbial genomics for routine public health microbiology. This technology...
Diagnostic error impacts millions of US adults and children every year1,2. Failure to order an appropriate diagnostic test and incorrect interpretation of diagnostic test results are co...
Appropriate dosing of pharmaceuticals is critical to prevent sub-therapeutic efficacy or the occurrence of adverse events. However, genetic variability may significantly influence an individu...
Introduction and adoption of whole-genome sequencing has enabled new methods of investigation in the quest for answers in diagnostic odyssey cases as well as in the broader study of genetic d...
As hospitals and healthcare systems move toward value-based care, new management systems are needed to measure and improve clinical processes. This presents both an opportunity and a ch...
Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical...
This lecture will provide attendees with the knowledge and skills to bring on new clinical laboratory tests in clinical chemistry and molecular diagnostics. The lecture will provide a general...
In November of 2013 the AHA/ACA jointly proposed new guidelines for the management of hypercholesterolemia, the first full update in over a decade. The charge was to create evidence bas...
Aggressive low-density lipoprotein cholesterol (LDL-C) lowering strategies are recommended for prevention of cardiovascular events in high-risk populations. Guidelines recommend a 30-50% redu...
Next-generation sequencing has emerged as a valuable tool for generating patient-specific genetic information for clinical diagnostics and optimal selection of targeted therapies. The heterog...
Family history can be viewed as the first stop in the assessment of genetic risks for any individual. For many genetic disorders there will be no obvious signs of symptoms until significant m...
In this presentation, Arvid Carlsson, who was awarded the Nobel prize in 2000 for his discovery of the transmitter role of dopamine, will be interviewed by Elias Eriksson. The following aspec...
9:00AM Pacific time, 11:00AM Central time, 12:00PM Eastern timeClinical Controversies Recently, both national and international authorities have promulgated conflicting statements on vita...
The advent of the microarray technology in 2000 has paved the way for advanced translational research methods that use molecular markers such as microRNA, proteins, metabolites and copy numbe...
Working with animals carries legal, scientific and ethical responsibilities. These responsibilities merge as we strive to humanely use the least number of animals necessary to provide t...
Optimising experimental design needs a sound understanding of basic principles and a good appreciation of a range of designs and when to use them. More than ten years ago it was clear t...
A number of elements come into the mix when trying to optimise experimental design. Among these are having clear objectives, setting up valid comparisons, knowing how to avoid bias during the...
DATE: February 3rd, 2016
TIME: 10am pacific time, 1pm eastern time
Instituting a laboratory outreach program achieves a multitude of benefits beyond driving optimization, test...
Date: December 9, 2015 10AM Pacific, 1PM Eastern
July 7, 2015, the U.S. Food and Drug Administration reviewed and approved ENTRESTO™ (sacubitril/valsartan) tablets to reduce the risk...
Live Webinar: December 2, 2015 8:00am PST
In recent years, there has been a dramatic increase in the number of new designer drugs designed to mimic the effects of controlled substances. &n...
Presence of anti-PS/PT IgG or IgM antibodies indicates a high risk category of patients
Antiphospholipid antibodies are not directed against phospholipids, but rather to phospholipid-prote...
Presence of anti-PS/PT IgG or IgM antibodies indicates a high risk category of patients
Antiphospholipid antibodies are not directed against phospholipids, but rather to phospholipid-prote...
DATE: November 19, 2015
TIME: 7:00AM Pacific, 9:00AM Central, 10:00AM Eastern, 3:00PM GMT
Diabetes represents a serious global epidemic. Diabetes causes its own direct adverse ...
The assessment of serum lipid and lipoprotein levels is a common procedure which affects the management of the risk of atherothrombotic cardiovascular disease (CVD) in large numbers of patien...
While genomics has been used as a tool for research for many years, globally there is increasing momentum to deploy microbial genomics for routine public health microbiology. This technology...
Diagnostic error impacts millions of US adults and children every year1,2. Failure to order an appropriate diagnostic test and incorrect interpretation of diagnostic test results are co...
Appropriate dosing of pharmaceuticals is critical to prevent sub-therapeutic efficacy or the occurrence of adverse events. However, genetic variability may significantly influence an individu...
Introduction and adoption of whole-genome sequencing has enabled new methods of investigation in the quest for answers in diagnostic odyssey cases as well as in the broader study of genetic d...
As hospitals and healthcare systems move toward value-based care, new management systems are needed to measure and improve clinical processes. This presents both an opportunity and a ch...
Medical Technology Partner’s presentation is designed highlight what Medicare is proposing to do based on the Protecting Access to Medicare Act of April 1, 2014 with regard to clinical...
This lecture will provide attendees with the knowledge and skills to bring on new clinical laboratory tests in clinical chemistry and molecular diagnostics. The lecture will provide a general...
In November of 2013 the AHA/ACA jointly proposed new guidelines for the management of hypercholesterolemia, the first full update in over a decade. The charge was to create evidence bas...
Aggressive low-density lipoprotein cholesterol (LDL-C) lowering strategies are recommended for prevention of cardiovascular events in high-risk populations. Guidelines recommend a 30-50% redu...
Next-generation sequencing has emerged as a valuable tool for generating patient-specific genetic information for clinical diagnostics and optimal selection of targeted therapies. The heterog...
Opens in a new windowOpens an external siteOpens an external site in a new window
Follow
